A

host of burgeoning fields in biomedicine — from personalized therapies and CRISPR gene editing to targeted tumor diagnostics — depend on the ability of labs to synthesize DNA on demand, cheaply and reliably.

Innovators in the field like San Francisco-based Twist Bioscience and Cambridge, Mass.-based Gen 9 use silicon wafers and microarrays to scale up the process, but are still using the same basic chemical techniques pioneered some 30 years ago. Now, a tiny ten-person startup in San Diego called Molecular Assemblies Inc. is nudging into the field with an entirely new process that uses enzymes instead of chemicals to create DNA. The technique was co-invented by one of the company’s founders, William Efcavitch, who also helped pioneered the chemical technique for synthesizing DNA that is in widespread use today.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.